Biblio

Export 751 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2019
L. Fani, Hilal, S., Sedaghat, S., Broer, L., Licher, S., Arp, P. P., van Meurs, J. B. J., M Ikram, K., and M Ikram, A., Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study., J Alzheimers Dis, vol. 73, no. 2, pp. 707-714, 2019.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
C. DeCarli, Villeneuve, S., Maillard, P., Harvey, D., Singh, B., Carmichael, O., Fletcher, E., Olichney, J., Farias, S., Jagust, W., Reed, B., and Mungas, D., Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury., J Alzheimers Dis, vol. 68, no. 1, pp. 187-196, 2019.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
2018
C. Babiloni, Del Percio, C., Lizio, R., Noce, G., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. Teresa, Catania, V., Nobili, F., Arnaldi, D., Famá, F., Aarsland, D., Orzi, F., Buttinelli, C., Giubilei, F., Onofrj, M., Stocchi, F., Vacca, L., Stirpe, P., Fuhr, P., Gschwandtner, U., Ransmayr, G., Garn, H., Fraioli, L., Pievani, M., Frisoni, G. B., D'Antonio, F., de Lena, C., Güntekin, B., Hanoğlu, L., Başar, E., Yener, G., Emek-Savaş, D. Durusu, Triggiani, A. Ivano, Franciotti, R., Taylor, J. Paul, De Pandis, M. Francesca, and Bonanni, L., Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases., J Alzheimers Dis, vol. 62, no. 1, pp. 247-268, 2018.
M. K. Lupton, Medland, S. E., Gordon, S. D., Goncalves, T., MacGregor, S., Mackey, D. A., Young, T. L., Duffy, D. L., Visscher, P. M., Wray, N. R., Nyholt, D. R., Bain, L., Ferreira, M. A., Henders, A. K., Wallace, L., Montgomery, G. W., Wright, M. J., and Martin, N. G., Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels., J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
E. Zupanic, Kåreholt, I., Norrving, B., Secnik, J., von Euler, M., Winblad, B., Religa, D., Kramberger, M. Gregoric, Johnell, K., Eriksdotter, M., and Garcia-Ptacek, S., Acute Stroke Care in Dementia: A Cohort Study from the Swedish Dementia and Stroke Registries., J Alzheimers Dis, vol. 66, no. 1, pp. 185-194, 2018.
T. L. Emmerzaal, Rodenburg, R. J., Tanila, H., Verweij, V., Kiliaan, A. J., and Kozicz, T., Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 1, pp. 75-82, 2018.
L. L. Ekblad, Toppala, S., Johansson, J. K., Koskinen, S., Sundvall, J., Rinne, J. O., Puukka, P., Viitanen, M., and Jula, A., Albuminuria and Microalbuminuria as Predictors of Cognitive Performance in a General Population: An 11-Year Follow-Up Study., J Alzheimers Dis, vol. 62, no. 2, pp. 635-648, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies., J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies., J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
L. Müller-Ehrenberg, Riphagen, J. M., Verhey, F. R. J., Sack, A. T., and Jacobs, H. I. L., Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes., J Alzheimers Dis, vol. 66, no. 2, pp. 811-823, 2018.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
W. M. van der Flier and Scheltens, P., Amsterdam Dementia Cohort: Performing Research to Optimize Care., J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
E. N. Cline, Bicca, M. Assunção, Viola, K. L., and Klein, W. L., The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade., J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study., J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study., J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.

Pages